Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease.
about
Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapyAnalysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infectionHigh-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.HIV preferentially infects HIV-specific CD4+ T cells.Neutralizing antibodies against autologous human immunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment.In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.Changes in function of HIV-specific T-cell responses with increasing time from infection.HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responsesCellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infectionDetection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients.Candidate vaccines for immunotherapy in HIV.Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero.Prospects for immune reconstitution in HIV-1 infection.Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assayDiminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferonsSIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaquesNovel peptide-based HIV-1 immunotherapy.A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapyDistinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infectionPirate primates in uncharted waters: lymphocyte transfers in unrelated, MHC-matched macaquesStructured treatment interruptions in HIV infection: benefit or disappointment?Use of cytokines in infection.Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication.Induction of a virus-specific effector-memory CD4+ T cell response by attenuated SIV infection.Dynamics of T-cell responses and memory T cells during primary simian immunodeficiency virus infection in cynomolgus macaques.Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women.Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapyCD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.Stress and body mass index each contributes independently to tumor necrosis factor-alpha production in prepubescent Latino children.Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levelsLong-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.CD4+ T cells from HIV-1-infected patients recognize wild-type and mutant human immunodeficiency virus-1 protease epitopes.Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.
P2860
Q24815428-BA8B9810-043D-4A8A-ABB4-9C1210AF58CFQ33869806-ED2B4B9C-73D4-4568-BAF8-CF83C571317AQ33950164-60B53743-9416-48B1-BF44-286F36011B60Q33958893-A7FDC7BD-C643-46E4-9171-39B8E5C84677Q33999316-F556E850-ACB4-42AB-9BD7-0CF0800B815DQ34050143-F3F8F9A2-9A98-4CD1-906D-1619F86983B9Q34142433-0C46908B-D2FE-465A-81C1-BBAB5B4394FFQ34190681-7C08DE65-F99F-4BDC-B803-1225413A12A1Q34325840-F3CC1328-154B-423A-9036-6C6DD36C18CBQ34344555-7E43FDB3-5D22-4D26-A2C6-9EE1F6152F2EQ34459401-29BDE911-32FC-472B-9A85-84F831053971Q34459435-C2518611-B893-4EA4-A447-AC98C6D6B27EQ34461381-902DADCC-4039-4FD9-865E-8EC020CD8CCDQ34609562-EB069C0C-062F-4500-BA76-F6621839C284Q34720316-AC9CE551-2D72-45A0-B8CF-927484D5A611Q35140055-8E0181BA-C070-48B5-8F23-91A1C30FEA7CQ35143735-0CD3F58A-6E03-4018-AAF1-2EA2184D45BCQ35684864-BBF535DE-478C-4D7F-88A2-F533D3DFA105Q35781698-F8ABB725-DD60-4FF0-918C-A13CFEDFDDC6Q35784244-D956B645-13A9-4345-AD0D-76A0426D53ADQ35874970-11C965F1-2467-4512-B7CA-41F3E0585124Q35917152-F7B3AF3A-C6AD-423A-A557-4AFCCB913DC6Q35967372-E5F6B91B-0C6D-4524-B383-A340AB008D9CQ36149329-53AE231F-DE58-4244-81B1-6CAA3BB050F3Q36228123-C13F61C0-A7E4-484E-8B46-DD7C478E8B38Q36315175-970987DF-99C1-4F71-AB71-07F4B0ADBD44Q36315197-BE9366EC-7261-452C-B058-BC38ADBD258DQ36371562-7D48EC98-1530-42F9-9EAD-271F2474C0D7Q36474240-39E04A4C-90E5-455C-8697-3DE0A71334DEQ36926499-922284BF-726F-4AC0-BDF4-AE8B4EC8F8DAQ37037090-B63D6E75-6D45-40E8-A071-3DA2A8CBC609Q37104112-31AD2D40-88D4-4256-9DB4-F5D852A82422Q37327826-0D9AAFF4-0AEC-42A7-89A5-376A93E31A69Q37419748-C94C9DF7-F8B0-4892-BC6F-5EF2E8C69F9CQ37422520-1CF09C54-709E-4941-94E9-231A498091E0Q37492797-6706CDAD-7BBE-4A00-BA75-DA58140898D3Q37596842-91B4A6D9-A44C-4F03-BDFE-70EF0B5F839FQ38086432-EBEF0E4C-EAEA-412A-A118-F77B069D9FCDQ39280285-D8D9B4C2-717D-486C-B0DE-78ADC431FC2EQ39683633-880824E1-2877-4232-B873-D6501E69B6A3
P2860
Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Loss of CD4+ T cell proliferat ...... s with progression to disease.
@en
Loss of CD4+ T cell proliferat ...... s with progression to disease.
@nl
type
label
Loss of CD4+ T cell proliferat ...... s with progression to disease.
@en
Loss of CD4+ T cell proliferat ...... s with progression to disease.
@nl
prefLabel
Loss of CD4+ T cell proliferat ...... s with progression to disease.
@en
Loss of CD4+ T cell proliferat ...... s with progression to disease.
@nl
P2093
P356
P1476
Loss of CD4+ T cell proliferat ...... s with progression to disease.
@en
P2093
P304
P356
10.1086/315764
P407
P577
2000-08-17T00:00:00Z